These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3628985)

  • 21. Immunization against anaplasmosis and babesiosis: Part I. Evaluation of immunization using minimum infective doses under laboratory conditions.
    González EF; Todorovic RA; Thompson KC
    Tropenmed Parasitol; 1976 Dec; 27(4):427-37. PubMed ID: 1006801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a nonviable culture-derived Babesia bovis vaccine.
    Kuttler KL; Levy MG; James MA; Ristic M
    Am J Vet Res; 1982 Feb; 43(2):281-4. PubMed ID: 7046534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological relationship between a large Babesia found in Japanese cattle and Babesia major, B bigemina and B bovis.
    Fujinaga T; Minami T; Ishihara T
    Res Vet Sci; 1980 Sep; 29(2):230-4. PubMed ID: 7008125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a Babesia bovis live attenuated vaccine.
    Alonso M; Blandino T; Mendoza E; Savon L; Camacho M
    Arch Med Res; 1994; 25(2):273-7. PubMed ID: 7919825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficiency of a recombinant MSA-2c-based ELISA to establish the persistence of antibodies in cattle vaccinated with Babesia bovis.
    Bono MF; Mangold AJ; Baravalle ME; Valentini BS; Thompson CS; Wilkowsky SE; Echaide IE; Farber MD; Torioni de Echaide SM
    Vet Parasitol; 2008 Nov; 157(3-4):203-10. PubMed ID: 18783887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Live vaccines against bovine babesiosis.
    de Waal DT; Combrink MP
    Vet Parasitol; 2006 May; 138(1-2):88-96. PubMed ID: 16504404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Babesia bigemina: attenuation of an Uzbek isolate for immunization of cattle with live calf- or culture-derived parasites.
    Shkap V; Rasulov I; Abdurasulov S; Fish L; Leibovitz B; Krigel Y; Molad T; Mazuz ML; Savitsky I
    Vet Parasitol; 2007 May; 146(3-4):221-6. PubMed ID: 17368728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure of a recombinant Babesia bovis antigen to protect cattle against heterologous strain challenge.
    Timms P; Barry DN; Gill AC; Sharp PJ; de Vos AJ
    Res Vet Sci; 1988 Sep; 45(2):267-9. PubMed ID: 3194602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tick-borne diseases in ruminants of Central and Southern Italy: epidemiology and case reports.
    Savini G; Conte A; Semproni G; Scaramozzino P
    Parassitologia; 1999 Sep; 41 Suppl 1():95-100. PubMed ID: 11071553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of an Australian Babesia bovis vaccine strain in Malawi.
    Lawrence JA; Malika J; Whiteland AP; Kafuwa P
    Vet Rec; 1993 Mar; 132(12):295-6. PubMed ID: 8470344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospects for recombinant vaccines against Babesia bovis and related parasites.
    Brown WC; Norimine J; Goff WL; Suarez CE; McElwain TF
    Parasite Immunol; 2006 Jul; 28(7):315-27. PubMed ID: 16842268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of novel immune correlates of protection against acute bovine babesiosis by superinfecting cattle with
    Bastos RG; Laughery JM; Ozubek S; Alzan HF; Taus NS; Ueti MW; Suarez CE
    Front Immunol; 2022; 13():1045608. PubMed ID: 36466866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoimmunoprophylaxis against bovine tropical theileriosis in young calves: a comparison between buparvaquone and long-acting oxytetracycline.
    Dhar S; Malhotra DV; Bhushan C; Gautam OP
    Res Vet Sci; 1990 Jul; 49(1):110-2. PubMed ID: 2382047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topically applied furazolidone or parenterally administered oxytetracycline for the treatment of infectious bovine keratoconjunctivitis.
    George L; Mihalyi J; Edmondson A; Daigneault J; Kagonyera G; Willits N; Lucas M
    J Am Vet Med Assoc; 1988 May; 192(10):1415-22. PubMed ID: 3292492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovine babesiosis: induction of a protective immune response with crude extracts of either Babesia bovis or B ovis.
    Alabay M; Duzgun A; Cerci H; Wright IG; Waltisbuhl DJ; Goodger BV
    Res Vet Sci; 1987 Nov; 43(3):401-2. PubMed ID: 3444987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential for recombinant Babesia bovis antigens to protect against a highly virulent isolate.
    Hope M; Riding G; Menzies M; Colditz I; Reverter A; Willadsen P
    Parasite Immunol; 2005 Dec; 27(12):439-45. PubMed ID: 16255742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection of cattle against Babesia major by the inoculation of irradiated piroplasms.
    Purnell RE; Brocklesby DW; Stark AJ
    Res Vet Sci; 1978 Nov; 25(3):388-90. PubMed ID: 749091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An immunisation trial with in vitro produced Babesia bigemina exoantigens.
    Beniwal RP; Nichani AK; Rakha NK; Sharma RD; Sarup S
    Trop Anim Health Prod; 1997 Nov; 29(4 Suppl):124S-126S. PubMed ID: 9512758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of Babesia divergens in cattle by oxytetracycline.
    Taylor SM; Elliott CT; Kenny J
    Vet Rec; 1986 Jan; 118(4):98-102. PubMed ID: 3952967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of acute ocular Moraxella bovis infections in calves with a parenterally administered long-acting oxytetracycline formulation.
    Smith JA; George LW
    Am J Vet Res; 1985 Apr; 46(4):804-7. PubMed ID: 4014830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.